title: Targeted therapies: Tivantinib--a cytotoxic drug in MET inhibitor's clothes?
authors.affiliation: Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy. paolo.michieli@ircc.it
authors.forename: Paolo
authors.initials: P
authors.lastname: Michieli
authors.forename: Federica
authors.initials: F
authors.lastname: Di Nicolantonio
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D006801:Humans; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D011760:Pyrrolidinones / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D050257:Tubulin Modulators / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D011760:Pyrrolidinones; D011804:Quinolines; D050257:Tubulin Modulators; D019859:Proto-Oncogene Proteins c-met